We use cookies to track website visits, but we do not store any personal information.

Accept cookiesDecline cookies

Have a question about CamAPS FX?

Here are the answers to some of your frequently asked questions.

What is CamAPS FX?

CamAPS FX is a sophisticated, easy-to-use mobile app to manage glucose levels in people with type 1 diabetes, aged one year and older, using an advanced adaptive hybrid closed-loop approach.

Is CamAPS FX approved for use?

The app has been extensively tested in clinical trials and approved for use including in the UK, the EU, the USA, Canada, Australia, and New Zealand.

Is CamAPS FX available in my area?

CamAPS FX is available in selected diabetes clinics. Please check with your clinic.

What CGMs are compatible with CamAPS FX?

CamAPS FX is compatible with Dexcom G6 and the FreeStyle Libre 3 . Please click the links to view compatible smartphones and operating systems.

What insulin pumps are compatible with CamAPS FX?

CamAPS FX available through Google Play is compatible with mylife YpsoPump insulin pump.   CamAPS FX available through Amazon Appstore is compatible with DANA Diabecare RS and DANA-i insulin pumps.

What smart phones are compatible with CamAPS FX?

CamAPS FX runs on an Android phone and is compatible with Android smartphone models supported by your CGM manufacturer.

Please click this link for a list of devices and operating systems compatible with the FreeStyle Libre 3 Sensor and the FreeStyle Libre 3 app.

From the 1st January 2025, CamAPS FX will only be supported on sensor-compatible phones running Android operating systems 10 and above. Users of operating systems below OS 10, will no longer be able to update or reinstall CamAPS FX after this date. 

Where can I upload my data to from CamAPS FX?

At present, data from CamAPS FX can be uploaded to mylife Cloud and Glooko.

What languages are available within CamAPS FX?

CamAPS FX is available in English, Czech, Danish, German, Spanish, French, Italian, Dutch, Polish, Finnish, and Swedish.

Where can I find the results of your clinical trials?

Publications related to the use of Cambridge control algorithm are available to download here. Key publications were published in The Lancet and The New England Journal of Medicine.

,,